EXCLUSIVE: Analysis: In Republican primaries, backing TrumpRx is increasingly becoming mandatory
U.S. President Donald Trump holds a signed executive order, as he attends a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. REUTERS/Nathan Howard
Support for President Trump’s TrumpRx initiative is rapidly emerging as a defining issue in Republican primaries, particularly in Florida, where two leading GOP candidates recently went public with strong endorsements of the program.
In recent days, the Washington Reporter exclusively reported that Florida congressional candidate Austin Rogers praised TrumpRx as a major achievement for lowering healthcare costs and helping working families afford prescription drugs. Rogers, a former top aide and general counsel to Sen. Rick Scott (R-Fla.), has quickly established himself as one of the most closely watched Republican candidates in Florida.
Shortly before that, the Reporter also exclusively reported that Florida candidate Michael Carbonara praised TrumpRx as a major win for seniors and Floridians struggling with prescription drug costs. Carbonara has built a significant profile in South Florida Republican politics as a businessman and heavily funded congressional candidate focused on affordability and economic issues.
The significance extends beyond two endorsements.
Florida remains one of the most important Republican states in the country. It is also a state where alignment with President Trump continues to carry enormous weight with GOP primary voters. Candidates running in competitive Republican primaries increasingly understand that publicly supporting Trump’s economic agenda is expected. TrumpRx is now becoming part of that equation.
The issue also gives Republicans a way to connect traditional Trump messaging with kitchen-table affordability concerns.
Candidates like Rogers and Carbonara are framing TrumpRx as part of a broader America First economic platform centered on lowering costs, helping seniors, supporting workers, and delivering tangible economic benefits to families squeezed by years of inflation.
The Washington Reporter has covered a growing number of Republicans praising TrumpRx in recent months. Trump-endorsed Alabama Senate candidate Rep. Barry Moore (R-Ala.) called the initiative “incredible” in an exclusive interview with the Reporter. The Reporter has also covered praise for the initiative from Sen. Tom Cotton (R-Ark.), Sen. John Barrasso (R-Wyo.), and multiple Republican candidates positioning themselves as strong Trump allies.
That trend is politically important because the support is increasingly coming from ambitious Republican candidates trying to establish conservative credibility inside competitive primaries.
In past cycles, some Republicans approached drug pricing issues cautiously. TrumpRx has shifted the politics surrounding the issue inside the GOP. Republican candidates are increasingly treating support for lowering prescription drug costs as consistent with Trump-style populist economics and the broader America First movement.
